Nuzenio

Primary End Point

Primary End Point news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Phase 3 Dermatomyositis Trial Sees Brepocitinib Meet Primary Endpoint - HCPLiveHCPLive · Sun, 09 Aug 2026 14:10:50 GMTSocrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study - HCPLiveHCPLive · Fri, 07 Aug 2026 23:10:36 GMTOral TYK2 Inhibitor Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Trial - Dermatology TimesDermatology Times · Fri, 07 Aug 2026 16:04:43 GMTNamilumab Fails to Meet Primary End Point in Pulmonary Sarcoidosis - HCPLiveHCPLive · Fri, 07 Aug 2026 14:06:13 GMTKaryopharm’s selinexor misses primary endpoint in Phase 3 endometrial cancer trial - The Clinical Trial VanguardThe Clinical Trial Vanguard · Sat, 01 Aug 2026 06:33:05 GMTSelinexor Phase 3 Trial Misses Primary Endpoint in Endometrial Cancer - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 31 Jul 2026 07:37:59 GMTKaryopharm’s XPORT-EC-042 study fails to meet primary endpoint - Clinical Trials ArenaClinical Trials Arena · Fri, 31 Jul 2026 07:00:00 GMTNovo Nordisk fails to meet primary endpoint in phase 3 trial - marketscreener.commarketscreener.com · Fri, 31 Jul 2026 07:00:00 GMT

Timeline

Sun, 09 Aug 2026 14:10:50 GMTPhase 3 Dermatomyositis Trial Sees Brepocitinib Meet Primary Endpoint - HCPLive
Fri, 07 Aug 2026 23:10:36 GMTSocrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study - HCPLive
Fri, 07 Aug 2026 16:04:43 GMTOral TYK2 Inhibitor Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Trial - Dermatology Times
Fri, 07 Aug 2026 14:06:13 GMTNamilumab Fails to Meet Primary End Point in Pulmonary Sarcoidosis - HCPLive
Sat, 01 Aug 2026 06:33:05 GMTKaryopharm’s selinexor misses primary endpoint in Phase 3 endometrial cancer trial - The Clinical Trial Vanguard
Fri, 31 Jul 2026 07:37:59 GMTSelinexor Phase 3 Trial Misses Primary Endpoint in Endometrial Cancer - The Clinical Trial Vanguard

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Primary End Point.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.